Log in to save to my catalogue

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melano...

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melano...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69d423c7d1ab4b458a345ad25ac7c05f

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

About this item

Full title

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

Publisher

England: BioMed Central Ltd

Journal title

Diagnostic pathology, 2020-12, Vol.15 (1), p.143-143, Article 143

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Identification of somatic mutations in key oncogenes in melanoma is important to lead the effective and efficient use of personalized anticancer treatment. Conventional methods focus on few genes per run and, therefore, are unable to screen for multiple genes simultaneously. The use of Next-Generation Sequencing (NGS) technologies enables sequencin...

Alternative Titles

Full title

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_69d423c7d1ab4b458a345ad25ac7c05f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69d423c7d1ab4b458a345ad25ac7c05f

Other Identifiers

ISSN

1746-1596

E-ISSN

1746-1596

DOI

10.1186/s13000-020-01052-5

How to access this item